Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03071835 · ClinicalTrials.gov registry record
A Comparative Study of Subjects Past Their Final Follow-ON Visit
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 47
- Enrollment target
NCT03071835: Completed study, sponsored by University of Miami.
NCT03071835 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03071835 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
A comparative study to follow subjects who received stem cell therapies three, five, seven, nine, and thirteen years after their follow-on visit. Subjects will be selected from a pool of previous Interdisciplinary Stem Cell Institute trial participants.
Primary Outcome
Demonstrate change of subject's symptoms by assessing cardiac events over an extended period of time following participation in an ISCI cardiac trial where the subject received Investigational product.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2016-06-23 |
| Est. Completion | 2023-10-01 |
What the finished NCT03071835 record still lists
NCT03071835 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03071835 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03071835 about?
NCT03071835 is a clinical study titled "A Comparative Study of Subjects Past Their Final Follow-ON Visit". A comparative study to follow subjects who received stem cell therapies three, five, seven, nine, and thirteen years after their follow-on visit. Subjects will be selected from a pool of previous Interdisciplinary Stem Cell Institute trial participants.
What is the current status of trial NCT03071835?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2016-06-23. Estimated completion is 2023-10-01.
Who is sponsoring clinical trial NCT03071835?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI